National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
ID: 349618Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349618

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity through the National Centers for Biomedical Imaging and Bioengineering (NCBIB) for the development of Biomedical Technology Resource Centers (BTRCs). This grant, under the P41 mechanism, aims to support research and development of innovative technologies that address emerging biomedical needs, with a focus on Technology Research and Development (TR&D) projects that foster collaboration among researchers. The initiative is crucial for enhancing biomedical technologies and facilitating training and dissemination of these technologies within the research community. Interested applicants should note that the grant does not require cost-sharing, has a maximum support period of five years, and the application deadline is September 7, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-235-Full-Announcement.html
    PAR-23-235.html
    The National Institutes of Health (NIH), specifically the National Institute of Biomedical Imaging and Bioengineering (NIBIB), has announced a funding opportunity within the National Centers for Biomedical Imaging and Bioengineering (NCBIB) to promote research and development of innovative technologies in biomedical research. The funding, under the P41 grant mechanism, allows applications for new, renewal, or resubmission projects, with a maximum support period of five years, limited to a total of 15 years. The NCBIB aims to enhance collaboration among researchers by providing essential technologies and training while fostering a nationwide impact through technology dissemination. The primary focus is on Technology Research and Development (TR&D) projects, which should address emerging biomedical needs and establish a synergistic relationship with Collaborative Projects (CPs) and Service Projects (SPs). Applicants are encouraged to submit Letters of Intent eight weeks prior to deadlines and to adhere strictly to the application requirements outlined in the guidance documents. This grant opportunity supports early-stage clinical trials but does not fund advanced phase trials. Overall, this funding initiative is integral to advancing biomedical technologies through collaborative and translational efforts in the research community.
    Similar Opportunities
    Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Biomedical Technology Optimization and Dissemination Centers (BTOD) aimed at supporting late-stage technology optimization and dissemination within the biomedical research community. This initiative encourages applications that focus on optimizing lab-proven technologies and enhancing their usability, with an emphasis on collaborative projects and community engagement strategies to ensure inclusivity and sustainability. Eligible applicants include a wide range of organizations such as educational institutions, nonprofits, and local governments, with a maximum annual budget of $850,000 available for funding, excluding specialized equipment costs. Interested parties should note that the application deadline is January 27, 2026, and can find further details and submission guidelines at the NIH grants website or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Notice of Intent to Publish a Notice of Funding Opportunity for National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is forecasting a Notice of Funding Opportunity (NOFO) for the National Centers for Biomedical Imaging and Bioengineering (NCBIB), with a focus on advancing research in biomedical imaging and bioengineering. This grant opportunity, identified as P41 Clinical Trials Optional, aims to foster meaningful collaborations and innovative projects within the research community. The anticipated funding amount for this initiative is up to $750,000, with the NOFO expected to be published in late summer 2023 and applications due in fall 2023. Interested applicants should prepare for the estimated project start date of July 30, 2024, and can expect the award announcement by June 30, 2024.
    Biomedical Technology Optimization and Dissemination Center (BTOD)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity for the Biomedical Technology Optimization and Dissemination Center (BTOD) program, aimed at optimizing late-stage biomedical technologies that have shown laboratory feasibility. The program's objective is to advance these technologies to a point of widespread use and promote their dissemination within the biomedical research community. This initiative is crucial for enhancing the application of innovative biomedical solutions, thereby contributing to advancements in health research. Interested applicants, including Indian/Native American Tribal Governments, eligible federal agencies, and community-based organizations, can reach out to Dr. Carolina Salvador Morales at carolina.salvadormorales@nih.gov or by phone at 301-480-0779 for further details. The estimated project start date is April 1, 2027, with a synopsis close date projected for May 28, 2026.
    Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Focused Technology Research and Development (R01 Clinical Trial Not Allowed) grant, aimed at supporting innovative technology projects that advance biomedical research. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities, Tribal Colleges, and various community-based organizations, with a focus on projects that demonstrate proof-of-concept and the development of working prototypes without integrating clinical trials. This initiative is crucial for fostering technological advancements that enhance understanding of biological processes, with no budget cap and a maximum project duration of five years. Interested applicants can find more information and application guidelines at NIH Grants, with proposals due by January 7, 2028.
    Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for exploratory research grants (R21) aimed at developing innovative technologies in biomedical research. This initiative seeks applications that propose high-risk, high-reward projects focused on technology development without existing proof of concept, specifically excluding clinical trials. The funding amount is capped at $275,000 in direct costs over two years, with a maximum of $200,000 available in any single year. Interested applicants, including higher education institutions and nonprofit organizations, must adhere to submission guidelines and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. The application deadline is January 7, 2028.
    Funding Opportunity Announcement - NIBIB Technology Development Networks
    National Institutes of Health
    The National Institutes of Health (NIH) is announcing a funding opportunity for the NIBIB Technology Development Networks, aimed at establishing Coordinating Centers that will facilitate collaboration among scientific and engineering communities to address translational challenges in health technology development. These centers will enhance integration across various technology development projects, disseminate program advancements, and manage an Opportunity Funds program to support promising small-scale initiatives. With an estimated total program funding of $1 million and a projected award ceiling of $1 million, this cooperative agreement is expected to yield one award, with applications not currently being solicited. Interested parties are encouraged to prepare for future submissions, with key dates including an estimated synopsis post date of May 1, 2026, and an estimated award date of April 1, 2027. For further inquiries, potential applicants can contact Luisa Russell via email at luisa.russell@nih.gov.
    Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Bioengineering Research Grants (BRG) under the R01 Clinical Trial Optional program, aimed at fostering collaborations between life and physical sciences to address biomedical challenges. The grants encourage multidisciplinary bioengineering approaches that integrate and accelerate the adoption of innovative tools and methods for research or clinical problems in basic, translational, or clinical science. This funding opportunity is particularly significant for small teams looking to enhance understanding and solve issues in biological and clinical sciences. Interested applicants can reach out to Dr. Miguel R. Ossandon at ossandom@mail.nih.gov or by phone at 240-276-5714, with an estimated award date of December 1, 2026, and a closing date for applications on February 5, 2026. The program anticipates awarding approximately 50 grants, with no cost-sharing or matching requirements.
    Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Animal and Biological Material Resource Centers" (P40) aimed at supporting specialized colonies of laboratory animals and related resources to enhance scientific rigor and reproducibility in biomedical research. This funding initiative encourages applicants to propose centers that not only continue existing resources but also develop new ones based on the needs of the biomedical research community, providing unique animal models, informatics tools, and biological materials applicable across multiple NIH Institutes. The total funding commitment is anticipated to be $1.3 million over three years, with at least two grants awarded annually, and interested applicants must adhere to strict application guidelines, with submissions accepted until January 28, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Exploratory/Developmental Bioengineering Research Grants (EBRG) program, aimed at enhancing biomedical research and clinical care. This initiative encourages innovative applications that focus on developing new capabilities to address challenges in biomedical, preclinical, or clinical settings, with an emphasis on feasibility testing and novel methodologies. The program is particularly significant for advancing cancer research through innovative bioengineering approaches, welcoming proposals from a diverse range of eligible applicants, including universities, nonprofits, and small businesses, especially those representing underrepresented groups. The maximum budget for applicants is $275,000 over two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html.